These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2823858)

  • 1. Etretinate modulates the leukotriene B4 induced intra-epidermal accumulation of polymorphonuclear leukocytes.
    Lammers AM; van de Kerkhof PC
    Br J Dermatol; 1987 Sep; 117(3):297-300. PubMed ID: 2823858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of leukotriene B4-induced intraepidermal accumulation of polymorphonuclear leukocytes by methotrexate in psoriasis.
    Lammers AM; van de Kerkhof PC; Mier PD
    Br J Dermatol; 1987 May; 116(5):667-71. PubMed ID: 3036194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukotriene B4 fails to induce penetration of polymorphonuclear leukocytes into psoriatic lesions.
    Lammers AM; van de Kerkhof PC
    Br J Dermatol; 1987 Nov; 117(5):541-4. PubMed ID: 2825753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukotriene B4-induced accumulation of polymorphonuclear leukocytes in psoriatic skin.
    van de Kerkhof PC; Lammers AM; Mier PD; Happle R
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():637-9. PubMed ID: 2823562
    [No Abstract]   [Full Text] [Related]  

  • 5. Response of polymorphonuclear leukocytes to topical leukotriene B4 in healthy and psoriatic skin.
    Lammers AM; van de Kerkhof PC
    Br J Dermatol; 1987 Apr; 116(4):521-4. PubMed ID: 3034322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate inhibits the leukotriene B4 induced intraepidermal accumulation of polymorphonuclear leukocytes.
    van de Kerkhof PC; Bauer FW; Maassen-de Grood RM
    Br J Dermatol; 1985 Sep; 113(3):251a-255a. PubMed ID: 2998429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis--enhancing properties of psoriatic serum.
    Ellis CN; Kang S; Grekin RC; Voorhees JJ; Silva J
    J Am Acad Dermatol; 1985 Sep; 13(3):437-43. PubMed ID: 4056118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etretinate therapy for psoriasis. Reduction of antibody-dependent cell-mediated cytotoxicity of polymorphonuclear leukocytes.
    Ellis CN; Kang S; Grekin RC; LoBuglio AF; Voorhees JJ
    Arch Dermatol; 1985 Jul; 121(7):877-80. PubMed ID: 4015133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ultrastructural study of transcutaneous migration of polymorphonuclear leukocytes following application of leukotriene B4.
    Paulissen M; Peereboom-Stegeman JH; van de Kerkhof PC
    Skin Pharmacol; 1990; 3(4):236-47. PubMed ID: 1964566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolism of leukotriene B4 by peripheral blood polymorphonuclear leukocytes in psoriasis.
    Maurice PD; Camp RD; Allen BR
    Prostaglandins; 1987 Jun; 33(6):807-18. PubMed ID: 2823314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dithranol modulates the leukotriene B4-induced intraepidermal accumulation of polymorphonuclear leukocytes.
    Chang A; Alkemade H; van de Kerkhof PC
    J Invest Dermatol; 1989 Jun; 92(6):806-8. PubMed ID: 2542415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement.
    Mahrle G; Schulze HJ; Färber L; Weidinger G; Steigleder GK
    J Am Acad Dermatol; 1995 Jan; 32(1):78-88. PubMed ID: 7822521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The responses of normal and psoriatic skin to single and multiple topical applications of leukotriene B4.
    Wong E; Camp RD; Greaves MW
    J Invest Dermatol; 1985 May; 84(5):421-3. PubMed ID: 2987362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etretinate or cyclosporin-A treatment normalizes the enhanced respiratory burst of polymorphonuclear leukocytes in psoriasis.
    Schopf RE; Höcher J; Rehder M; Färber L; Morsches B
    Arch Dermatol Res; 1992; 284(4):227-31. PubMed ID: 1417069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Areca nut extracts-activated secretion of leukotriene B4, and phosphorylation of p38 mitogen-activated protein kinase and elevated intracellular calcium concentrations in human polymorphonuclear leukocytes.
    Hung SL; Lin YJ; Chien EJ; Liu WG; Chang HW; Liu TY; Chen YT
    J Periodontal Res; 2007 Oct; 42(5):393-401. PubMed ID: 17760816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical application of clobetasol-17-propionate inhibits the intra-epidermal accumulation of polymorphonuclear leukocytes.
    Chang A; van de Kerkhof PC
    Acta Derm Venereol; 1988; 68(1):57-60. PubMed ID: 2449013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of etretinate on the cyclo-oxygenase and lipoxygenase products of arachidonic acid metabolism in psoriatic skin.
    Wong E; Barr RM; Brain SD; Greaves MW; Olins LA; Mallet AI
    Br J Clin Pharmacol; 1984 Oct; 18(4):523-7. PubMed ID: 6091710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of topical retinoids on the leukotriene-B4-induced migration of polymorphonuclear leukocytes into human skin.
    Wozel G; Chang A; Zultak M; Czarnetzki BM; Happle R; Barth J; van de Kerkhof PC
    Arch Dermatol Res; 1991; 283(3):158-61. PubMed ID: 1651071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epicutaneous application of leukotriene B4 induces patterns of tenascin and a heparan sulfate proteoglycan epitope that are typical for psoriatic lesions.
    Seyger MM; van Pelt JP; van den Born J; Latijnhouwers MA; de Jong EM
    Arch Dermatol Res; 1997 May; 289(6):331-6. PubMed ID: 9209678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PUVA and UVB inhibit the intra-epidermal accumulation of polymorphonuclear leukocytes.
    Chang A; Alkemade JA; van de Kerkhof PC
    Br J Dermatol; 1988 Sep; 119(3):281-7. PubMed ID: 2846029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.